434 related articles for article (PubMed ID: 30914432)
1. Long Noncoding RNA MALAT1 Regulates Cancer Glucose Metabolism by Enhancing mTOR-Mediated Translation of TCF7L2.
Malakar P; Stein I; Saragovi A; Winkler R; Stern-Ginossar N; Berger M; Pikarsky E; Karni R
Cancer Res; 2019 May; 79(10):2480-2493. PubMed ID: 30914432
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA MALAT1 Promotes Hepatocellular Carcinoma Development by SRSF1 Upregulation and mTOR Activation.
Malakar P; Shilo A; Mogilevsky A; Stein I; Pikarsky E; Nevo Y; Benyamini H; Elgavish S; Zong X; Prasanth KV; Karni R
Cancer Res; 2017 Mar; 77(5):1155-1167. PubMed ID: 27993818
[TBL] [Abstract][Full Text] [Related]
3. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling.
He B; Peng F; Li W; Jiang Y
J Cell Biochem; 2019 Mar; 120(3):2908-2918. PubMed ID: 30500989
[TBL] [Abstract][Full Text] [Related]
4. LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway.
Zheng YL; Li L; Jia YX; Zhang BZ; Li JC; Zhu YH; Li MQ; He JZ; Zeng TT; Ban XJ; Yuan YF; Li Y; Guan XY
Theranostics; 2019; 9(3):796-810. PubMed ID: 30809309
[No Abstract] [Full Text] [Related]
5. Long Noncoding RNA MALAT1 Regulates Hepatocellular Carcinoma Growth Under Hypoxia via Sponging MicroRNA-200a.
Zhao ZB; Chen F; Bai XF
Yonsei Med J; 2019 Aug; 60(8):727-734. PubMed ID: 31347327
[TBL] [Abstract][Full Text] [Related]
6. mTOR regulates aerobic glycolysis through NEAT1 and nuclear paraspeckle-mediated mechanism in hepatocellular carcinoma.
Zhang H; Su X; Burley SK; Zheng XFS
Theranostics; 2022; 12(7):3518-3533. PubMed ID: 35547764
[No Abstract] [Full Text] [Related]
7. Promotion of glycolysis by HOTAIR through GLUT1 upregulation via mTOR signaling.
Wei S; Fan Q; Yang L; Zhang X; Ma Y; Zong Z; Hua X; Su D; Sun H; Li H; Liu Z
Oncol Rep; 2017 Sep; 38(3):1902-1908. PubMed ID: 28731193
[TBL] [Abstract][Full Text] [Related]
8. Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer.
Wang J; Wang H; Zhang Y; Zhen N; Zhang L; Qiao Y; Weng W; Liu X; Ma L; Xiao W; Yu W; Chu Q; Pan Q; Sun F
Cell Signal; 2014 May; 26(5):1048-59. PubMed ID: 24468535
[TBL] [Abstract][Full Text] [Related]
9. LncRNA-MALAT1 Regulates Cancer Glucose Metabolism in Prostate Cancer via MYBL2/mTOR Axis.
Mu X; Shen Z; Lin Y; Xiao J; Xia K; Xu C; Chen B; Shi R; Zhu A; Sun X; Tao T; Song X; Xuan Q
Oxid Med Cell Longev; 2022; 2022():8693259. PubMed ID: 35557985
[TBL] [Abstract][Full Text] [Related]
10. Sp1 cooperates with Sp3 to upregulate MALAT1 expression in human hepatocellular carcinoma.
Huang Z; Huang L; Shen S; Li J; Lu H; Mo W; Dang Y; Luo D; Chen G; Feng Z
Oncol Rep; 2015 Nov; 34(5):2403-12. PubMed ID: 26352013
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA MALAT1 Regulates ZEB1 Expression by Sponging miR-143-3p and Promotes Hepatocellular Carcinoma Progression.
Chen L; Yao H; Wang K; Liu X
J Cell Biochem; 2017 Dec; 118(12):4836-4843. PubMed ID: 28543721
[TBL] [Abstract][Full Text] [Related]
12. lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARγ pathway in hepatocellular carcinoma.
Li X; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
Int J Oncol; 2018 Aug; 53(2):551-566. PubMed ID: 29845188
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Tang Y; Xiao G; Chen Y; Deng Y
Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
[TBL] [Abstract][Full Text] [Related]
14. Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression.
Jen J; Tang YA; Lu YH; Lin CC; Lai WW; Wang YC
Mol Cancer; 2017 Jun; 16(1):104. PubMed ID: 28615056
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
[TBL] [Abstract][Full Text] [Related]
16. The long noncoding RNA NEAT1 contributes to hepatocellular carcinoma development by sponging miR-485 and enhancing the expression of the STAT3.
Zhang XN; Zhou J; Lu XJ
J Cell Physiol; 2018 Sep; 233(9):6733-6741. PubMed ID: 29219178
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma.
Toraih EA; Ellawindy A; Fala SY; Al Ageeli E; Gouda NS; Fawzy MS; Hosny S
Biomed Pharmacother; 2018 Jun; 102():653-669. PubMed ID: 29604585
[TBL] [Abstract][Full Text] [Related]
18. Sp1-mediated transcriptional regulation of MALAT1 plays a critical role in tumor.
Li S; Wang Q; Qiang Q; Shan H; Shi M; Chen B; Zhao S; Yuan L
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1909-20. PubMed ID: 25773124
[TBL] [Abstract][Full Text] [Related]
19. CCL21 activation of the MALAT1/SRSF1/mTOR axis underpins the development of gastric carcinoma.
Fu Q; Tan X; Tang H; Liu J
J Transl Med; 2021 May; 19(1):210. PubMed ID: 34001131
[TBL] [Abstract][Full Text] [Related]
20. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
Yang X; Sun L; Wang L; Yao B; Mo H; Yang W
Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]